Naloxone prevents cell‐mediated immune alterations in adult mice following repeated mild stress in the neonatal period
- 1 March 2002
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 135 (5) , 1219-1226
Abstract
Mild stress plus mild pain (solvent injection) applied daily to neonatal mice induces hormonal, behavioural and metabolic changes perduring in the adult life. We investigated whether daily mild stress to neonatal mice induces also long‐term defined changes of immune response, and whether immune changes are prevented through repeated administration of the opioid antagonist naloxone. Mild stress plus solvent injection administered from birth to the 21st postnatal day causes not only behavioural and metabolic changes, but also long‐term (up to 110 days of life) splenocytes modifications, consisting in: increased release of the Th‐1 type cytokines interleukin‐2 (IL‐2) (from an average of 346 to 788 pg ml−1), interferon‐γ (from 1770 to 3942) and tumour necrosis factor‐α (from 760 to 1241); decreased release of the Th‐2 type cytokines IL‐4 (from 49.1 to 28.4) and IL‐10 (from 1508 to 877). Moreover, enhanced natural killer‐cell activity; enhanced proliferative splenocytes properties in resting conditions and following phytohemoagglutinin and concanavalin‐A stimulation are observed. Immunological, behavioural and metabolic changes are prevented by the opioid antagonist (−)naloxone (1 mg kg−1 per day s.c., administered instead of solvent) but not by the biologically inactive enantiomorph (+)naloxone. In conclusion, endogenous opioid systems sensitive to naloxone are involved in long‐lasting enhancement of the Th‐1 type cytokines and cell‐mediated immunological response caused by repeated mild stress administered postnatally. British Journal of Pharmacology (2002) 135, 1219–1226; doi:10.1038/sj.bjp.0704577Keywords
This publication has 53 references indexed in Scilit:
- The Effects of Early Rearing Environment on the Development of GABAA and Central Benzodiazepine Receptor Levels and Novelty-Induced Fearfulness in the RatNeuropsychopharmacology, 2000
- Persistent Effects of Maternal Deprivation on HPA Regulation Can Be Reversed By Feeding and Stroking, But Not By DexamethasoneJournal of Neuroendocrinology, 1999
- Glucocorticoids induce the expression of the leptin gene through a non‐classical mechanism of transcriptional activationEuropean Journal of Biochemistry, 1998
- β-endorphin in the immune system: a role at last?Immunology Today, 1997
- Evolution of daytime quiet sleep components in early treated phenylketonuric infantsBrain and Development, 1996
- Neonatal handling alters serotonin (5-HT) turnover and 5-HT2 receptor binding in selected brain regions: relationship to the handling effect on glucocorticoid receptor expressionDevelopmental Brain Research, 1994
- Immunomodulating properties of carbamazepine in miceInternational Journal of Immunopharmacology, 1992
- Chronic treatment with MIF-1 prevents the painful stimuli threshold elevation induced by neonatal handling in micePeptides, 1991
- Pharmacology of DynorphinAnnual Review of Pharmacology and Toxicology, 1988
- Circadian and seasonal rhythm in stimulation-produced analgesiaCellular and Molecular Life Sciences, 1981